Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit Parkinson’s Europe website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Tony Seidl finishes

Perspectives

Tony’s two-wheel tour: “One of the best experiences of my life”

Tony reflects on his experience, which might just be the best of his life

READ MORE

Global update

Thousands of campaigners from 170 countries set to #UniteForParkinsons

The campaign receives endorsement in European Parliament

READ MORE
vegetarian-chilli-sin-carne

Recipes & Nutrition

Slow-cooked vegetarian chilli ‘sin carne’ with aubergine

Try this deliciously rich chilli con carne – without the 'carne'

READ MORE